Arkolith/Insider Trading/BVS/Form 4

Singleton Mark Leonard

SVP & CFOBioventus Inc. (BVS) · full profile →Form 4 · filed Mar 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Option exercise(M)14K—$0165K
Mar 13, 2026Tax withholding(F)6K$8.62$51K159K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Grant(A)104K—$0104K
Mar 13, 2026Option exercise(M)14K—$041K
Mar 13, 2026Grant(A)116K—$0116K
Mar 14, 2025Grant(A)54K—$054K
Mar 14, 2025Grant(A)61K—$061K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001914936-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Bioventus Inc.

Build

Ask your agent about BVS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001914936-26-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Bioventus Inc.
over the last 90 days and cite the filings.